Every business has a story to tell, our team story started 15 years ago, the team aim was to help a family member who suffer from Diabetes Mellitus which led to Several years of intensive research which were focused on a combination of several Herbs that are recognized in antiquity possessing real health effects on Diabetes it was probably the way to proceed accordingly, refining the herbs combination, specifying extraction techniques, checking and improving safety and dosing.
The whole study was followed by a Clinical Trial on type 2 diabetic patients assessing the effect on blood sugar control and safety / tolerability of the treatment. The results were stunning, with safe and significant control of blood sugars, blood fats and in some cases a remarkable reversal of established visual, circulatory and kidney problems. Importantly, only few patients suffer from side effects, none of them severe.
Ascarx is patented granted in Israel and Europe plus countries in the far East. Ascarx was recognized as safe ( GRAS ), Ascarx have an FDA Certificate of Registration.
Founded in Israel in 2004 by Dr. Dov Fogel, Ascarit developed proprietary botanical supplement for metabolic diseases. Extensive research, including work on herbal extraction techniques, dry-powder conversion and safety evaluation led to Ascarx, Ascarit’s flagship product.
It is an herbal-based Nutrient Supplement with remarkable ability to help control glucose level in the blood and Normalizing lipid properties.
Clinical trial demonstrated Ascarx’s ability to control blood sugar levels. Ascarit Ltd. has signed an R&D association agreement with Maccabi Health Care, an Israeli Health Services Supplier, for research and development of AscaRx in Israel.
Dr. Dov Fogel MD Ph.D - Ascarit Ltd. Founder & CTO
Dr. Fogel studied medicine in Bologna (Italy) and graduated at the faculty of medicine in the Technion Israel Institute of technology. He has practiced as a pediatric consultant since 1983 and for the last 8 years is the executive director of two large medical clinics providing pediatric and adult multidisciplinary medical care. Since 2003, he has been busy developing and researching the potential effect of Supplements in metabolic diseases such as diabetes mellitus. His work has focused particularly on the development of Ascarx, a Botanical complex of several active herbal constituents, with balancing effect on blood glucose and lipid. The study included identifying the herbal constituents and its metabolically activity including study on the safety for humans.
Scientific Advisory Board
Prof. Alf Fischbein M.D
Prof. Fischbein is an international authority in Environmental Health. A graduate of the Faculty of Medicine of the University of Lund, Sweden, he has been Associate Professor at the Mount Sinai School of Medicine of the City University of New York and Visiting Professor at Sackler School of Medicine, Tel Aviv University. He has expertise in a wide spectrum of biomedical sciences and occupational medicine and has pioneered the development and application of bioactive natural products and innovative diagnostic devices. He has co-developed and implemented protocols for clinical trials of pharmaceuticals, which have gained US FDA approval. He is currently active in the field of biotechnology and regenerative medicine, focusing on natural, herbal and OTC products and collaborates with an international network of medical scientists, pharmaceutical companies, as well as manufacturers and distributors of pharmaceuticals, herbal medicines and medical devices.
Dr. Sumit Chatterji MA MB BChir (Cantab) FRCP (London)Dr. Sumit Chatterji graduated in medicine from the University of Cambridge in 1999. He completed his house jobs then specialist training in the East of England deanery and has been on the specialist register in pulmonology and internal medicine since 2009. His specialist training included over 18 months in the renowned Sleep Unit in Papworth Hospital (UK) with experience of managing complex metabolic and neuromuscular disorders. In addition, he pursued a training sabbatical in interventional pulmonology at the Beth Israel Deaconess hospital, Boston USA, Thoraxklinik , Heidelberg Germany and Toronto General hospital. Following this he has worked as a pulmonologist and internist in Peterborough and Stamford Hospitals and the main teaching hospital in Cambridge, Addenbrooke’s Hospital, with leadership in respiratory diagnostics, pulmonary physiology, sleep medicine and respiratory procedural education. He is currently a pulmonologist specializing in interventional pulmonology at Sheba Medical Centre, Israel and the director of the Pleural service. He is the founder and director of the award-winning educational sites and www.easternchestdraincourse.co.uk, has authored several book chapters in medicine and research papers in peer-reviewed journals. His main clinical interests are respiratory diagnostics / interventions, thoracic ultrasound applications and procedural medical education.
Dr. Rafael Bitzur M.D
Dr. Bitzur is a senior physician at the Bert W. Strassburger Lipid Centre, Sheba Medical Center, Israel. He is in charge of the LDL apheresis service in the hospital. He is the current Secretary of the Israeli Atherosclerosis society. He has extensive experience participating in both basic and clinical studies multi-center, international Phase II and III clinical trials of new medications aimed at lowering blood lipid levels and cardiovascular risk. His involvement includes pre-trial planning (including obtaining the Ethics Committee approval) and the actual execution of the trials.
Dr. Vardit Kalamaro
Dr. Vardit Kalamaro, holds a PharmD in clinical pharmacology from the Hebrew University of Jerusalem and is engaged in Medication Therapy Management (MTM) Services for the past 3 years at DRPHARMA.CO.IL.
Since her graduation in 2003, Dr. Kalamaro served as head clinical pharmacy services at the Israel Cystic Fibrosis Foundation as part of a multidisciplinary health care team within medical centers (Hadassah, Tel-Hashomer, Schneider, Soroka and Beilinson).
Dr. Kalamaro is active in promoting the involvement of clinical pharmacists as part of a vital health care profession. She is the chairlady of The Clinical Pharmacy Association and council member of The Pharmaceutical Society of Israel for the past 6 years.